✦ LIBER ✦

A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis

✍ Scribed by Paul H. Gordon

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 59 KB
Volume: 39
Category: Article
ISSN: 0148-639X
DOI: 10.1002/mus.21354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A clinical trial of verapamil in amyotro

A clinical trial of verapamil in amyotrophic lateral sclerosis

✍ R. G. Miller; S. A. Smith; J. R. Murphy; James R. Brinkamann; Joretta Graves; Mi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB

A placebo-controlled trial of recombinan

A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis

✍ Dr. Robert G. Miller; Jack H. Petajan; Wilson W. Bryan; Carmel Armon; Richard J. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 1 views

There is no satisfactory treatment for amyotrophic lateral sclerosis (ALS) [ 11. Ciliary neurotrophic factor (CNTF) is an endogenous protein that is released upon injury to the nervous system and limits the extent of injury-induced tieuronal damage in some nerve cells [2, 31. CNTF can be produced in

Expression of Nogo-A in human muscle fib

Expression of Nogo-A in human muscle fibers is not specific for amyotrophic lateral sclerosis

✍ Valerie Askanas; Slawomir Wojcik; W. King Engel 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 2 views